Skip to main content
. 2022 Sep 24;13:5614. doi: 10.1038/s41467-022-33210-2

Fig. 2. Comprehensive analyses of all fusions in EGFR mutant lung cancer.

Fig. 2

Prospectively collected genetic data on fusions from all cancer patients, and mutational data from patients with non-small cell lung cancer (NSCLC; detected by OncoPanel at Dana Farber Cancer Institute) were combined. Unique fusions identified in patients with EGFR L858R or deletion in exon 19 (del19) were classified into five groups.